In addition, downregulation of c-IAP1 and c-IAP2, which leads to the inhibition of NF-κB activation, could enhance the chemosensitivity of CRC cells to CPT-11 (Yu et al. 2014). Here, BIRC2 is linked to colorectal carcinoma.